It was confirmed that treatment with 5’-AzaC decreased the expression of inflammatory cytokines (i.e., TNF-α and IL-6) in RAFLS.442 Furthermore, 5’-AzaC elevated the anti-inflammatory cytokine IL-10 expression in PBMCs isolated from RA patients. The gene discussed is IL10; the disease is rheumatoid arthritis.